BECONASE HAYFEVER RELIEF 180 DOSES

BECONASE HAYFEVER RELIEF FOR ADULTS
Alternate Name:
Beclomethasone Nasal Spray
Strength: 50mcg
Pack Quantity: 180dose

50 micrograms beclomethasone dipropionate per spray

Beconase Hayfever Relief for Adults is indicated for the treatment of seasonal allergic rhinitis (hayfever) in adults aged 18 and over.

It is an Aqueous nasal spray containing 50 micrograms beclomethasone dipropionate per spray

A highly effective medication for treating and preventing airborne allergies such as hayfever dust and pet allergy any time during the year

Do not use; more than 4 sprays in each nostril in a day; for more than 3 months continuously without consulting your doctor

Two sprays into each nostril every morning and evening. 

Not for use in children or adolescents under 18 years

Adults aged 18 and over: The recommended dosage is two sprays into each nostril morning and evening (400 micrograms/day). 

A dosage regimen of one spray into each nostril morning and evening has been shown to be efficacious in some patients. 

However, should the symptoms recur, patients should revert to the recommended dosage of two sprays into each nostril morning and evening. 

The minimum dose should be used at which effective control of symptoms is maintained.  Total daily administration should not exceed eight sprays (400 micrograms). 

Beconase Hayfever Relief for Adults quickly starts to reduce inflammation and swelling in the nose.  For full therapeutic benefit Beconase Hayfever Relief for Adults should be used regularly. 

If symptoms have not improved after 7 days treatment, medical advice must be sought. 

Beconase Hayfever Relief for Adults is not recommended for children or adolescents under 18 years of age. 

Contraindications
Beconase Hayfever Relief for Adults is contra-indicated in patients with a history of hypersensitivity to any of its components. 

Special warnings and precautions for use
Systemic effects of nasal corticosteroids may occur, particularly at high doses when used for prolonged periods. 

Treatment with higher than recommended doses may result in clinically significant adrenal suppression. 

Medical advice should be sought before using Beconase Hayfever Relief for Adults by patients using other forms of corticosteroid treatments such as asthma medications, tablets, injections, similar nasal sprays, eye or nose drops, creams, ointments. 

This product should not be used continuously for longer than 1 month without medical advice. 

Although Beconase Hayfever Relief for Adults will control seasonal allergic rhinitis in most cases, an abnormally heavy challenge of summer allergens may, in certain instances, necessitate appropriate additional therapy particularly to control eye symptoms. 

Medical advice should be sought before using Beconase Hayfever Relief for Adults in the case of recent injury or surgery to the nose, or problems with ulceration in the nose. 

Pregnancy and lactation
There is inadequate evidence of safety in human pregnancy.  Administration of corticosteroids to pregnant animals can cause abnormalities of fetal development including cleft palate and intra-uterine growth retardation.  There may therefore be a very small risk of such effects in the human fetus.  It should be noted, however, that the fetal changes in animals occur after relatively high systemic exposure. 

Beconase Hayfever Relief for Adults delivers beclometasone dipropionate directly to the nasal mucosa and so minimises systemic exposure. 

The use of beclometasone dipropionate should be avoided during pregnancy unless thought essential by the doctor. 

Lactation: No specific studies examining the transference of beclometasone dipropionate into the milk of lactating animals have been performed.  It is reasonable to assume that beclometasone dipropionate is secreted in milk, but at the dosages used for direct intranasal administration there is low potential for significant levels in breast milk. 

Beconase Hayfever Relief for Adults should not be used during lactation without consulting a doctor.